Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial.

Fiche publication

Date publication

novembre 2025

Journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BENGRINE-LEFEVRE Leila

Tous les auteurs :
Beinse G, Leroy K, Just PA, Jeanne C, Cherifi F, Leary A, Le Saux O, You B, Rodrigues M, Gladieff L, Abadie-Lacourtoisie S, Lefevre LB, Brachet PE, Lebreton C, Meynard G, Fournel P, Frenel JS, Selle F, Largillier R, Foa C, Cornila C, Fernandez Diez Y, Bonnet E, Arnaud A, Kaczmarek E, Follana P, Bouchaert P, Joly F, Alexandre J, Leman R

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41418627

Résumé

We aimed to describe the association between molecular sub-groups and outcomes in patients with advanced/metastatic endometrial carcinoma amenable to maintenance/active surveillance after carboplatin-based chemotherapy.